<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00225680</url>
  </required_header>
  <id_info>
    <org_study_id>524</org_study_id>
    <nct_id>NCT00225680</nct_id>
  </id_info>
  <brief_title>In Stent ELUTES Study</brief_title>
  <acronym>ELUTES II</acronym>
  <official_title>ELUTES II - In Stent ELUTES Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cook Group Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cook Group Incorporated</source>
  <brief_summary>
    <textblock>
      This trial will compare the long term safety and effectiveness of the V Flex Plus PTX Drug
      Eluting coronary stent with conventional treatment for in-stent restenosis for coronary
      arteries.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2002</start_date>
  <completion_date>August 2005</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Angiographic target vessel failure (TVF) at follow up</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major adverse events</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion revascularization</measure>
  </secondary_outcome>
  <enrollment>124</enrollment>
  <condition>Coronary Artery Disease</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>drug eluting coronary stent</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient has given informed consent

          -  Patient has target lesion in native coronary artery or coronary bypass graft

          -  Patient has in-stent restenosis &gt;60%

          -  Patient has reference artery diameter 2.7-3.5

          -  Patient agrees to return for clinical assessment at 1, 6, 9, 12 and 24 months and for
             a treadmill test at 9 months and an angiogram at 9 months and 24 months.

        Exclusion Criteria:

          -  Patient is less than 18 years of age

          -  Patient is pregnant or breast feeding

          -  Patient has history of bleeding diathesis or coagulopathy or will refuse blood
             transfusions.

          -  Patient is simultaneously participating in another investigative interventional
             cardiovascular drug or device study.

          -  Patient has known hypersensitivity or contraindication to aspirin or stainless steel
             or a sensitivity to contrast agent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ivan DeScheerder, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Gathuisberg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Contact Sponsor</name>
      <address>
        <city>Bloomington</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 23, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 26, 2005</study_first_posted>
  <last_update_submitted>January 30, 2012</last_update_submitted>
  <last_update_submitted_qc>January 30, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 1, 2012</last_update_posted>
  <keyword>coronary artery</keyword>
  <keyword>stent</keyword>
  <keyword>drug eluting</keyword>
  <keyword>patency</keyword>
  <keyword>restenosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

